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Abstract
Background: Our aim was to compare access to effective care among elderly Medicare patients
in a Staff Model and Group Model HMO and in Fee-for-Service (FFS) care.
Methods: We used a retrospective cohort study design, using claims and automated medical
record data to compare achievement on quality indicators for elderly Medicare recipients.
Secondary data were collected from 1) HMO data sets and 2) Medicare claims files for the time
period 1994–95. All subjects were Medicare enrollees in a defined area of New England: those
enrolled in two divisions of a managed care plan with different physician payment arrangements: a
staff model, and a group model; and the Medicare FFS population. We abstracted information on
indicators covering several domains: preventive, diagnosis-specific, and chronic disease care.
Results: On the indicators we created and tested, access in the single managed care plan under
study was comparable to or better than FFS care in the same geographic region. Percent of
Medicare recipients with breast cancer screening was 36 percentage points higher in the staff model
versus FFS (95% confidence interval 34–38 percentage points). Follow up after hospitalization for
myocardial infarction was 20 percentage points higher in the group model than in FFS (95%
confidence interval 14–26 percentage points).
Conclusion: According to indicators developed for use in both claims and automated medical
record data, access to care for elderly Medicare beneficiaries in one large managed care
organization was as good as or better than that in FFS care in the same geographic area.
Background
Over 32 million elderly Americans are enrolled in the
Medicare health insurance program. Since 1982, the
Health Care Financing Administration has offered a
managed care option, with capitated payment, to Medi-
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care enrollees. Currently nearly 15% of Medicare enroll-
ees are members of managed care plans nationwide. [1]
The economic incentives of capitated payment have
raised concerns that managed care organizations that
use capitation might limit provision of effective services
as a way of trimming costs. [2–5] Public concerns about
restriction of service in managed care organizations have
led to proposed legislation for a "patient's bill of
rights."[6] once again being considered in the US Senate.
[7] It is becoming clear, however, that "managed care" is
not a single entity, and that a wide range of economic in-
centives and disincentives may be created in various
forms of managed care, [8] each likely to have different
kinds of influence on clinician behavior. [9–11] The prox-
imity of risk to the clinician or clinician group has an es-
pecially strong effect on behavior. [12] Systems
maintained by managed care organizations to assist cli-
nicians in providing quality care also differ widely, and
may strongly influence performance.
Although reduced access to care is a theoretical risk of
capitated payment, relatively few studies have addressed
whether this concern is borne out in practice. Perhaps
because of the variation in managed care arrangements,
the results of studies have been mixed. [13] If managed
care presents barriers to access to effective care, the eld-
erly would be especially vulnerable because they have a
higher burden of illness than the rest of the population.
We therefore created indicators in several domains for
which it was known that care improved outcomes. We
then used these indicators to compare health care re-
ceived by elderly Medicare beneficiaries in three kinds of
payment arrangements: a capitated, staff-model health
maintenance organization (HMO) and a partially capi-
tated group-model HMO, both parts of the same man-
aged care organization, and in fee-for-service (FFS) care
in the same geographic area.
Methods
Study site
The managed care plan participating in this study, Har-
vard Pilgrim Health Care (HPHC), is the largest HMO in
New England, and is a not-for profit entity. It was begun
in 1981 as Harvard Community Health Plan, a Staff Mod-
el HMO that at the time of this study comprised about
300,000 members at fourteen health centers in the
greater Boston area. Harvard Pilgrim Health Care had
grown by merger to include, among its divisions, one
made up of non-exclusive medical groups; at the time of
this study the Group Model HMO cared for about
186,000 members in eastern Massachusetts.
For both divisions, the Medicare enrollees eligible for
this study included all those age 65 and older who were
members for part or all of the period January 1, 1994
through December 31, 1995. Almost 10,000 members
from the Staff Model and 5,000 in the Group Model met
these criteria. Members who switched from one division
to the other during the study period (497 members, 2
percent of the combined samples) were not included in
the study. Samples were defined separately for each indi-
cator (see Tables and 1Additional file Indicator Defini-
tions).
Staff model HMO
The Staff Model division of HPHC provided primary
care-based, multi-specialty care. The organization has
cared for aged Medicare patients in risk and other com-
mercial plans since the mid-1980's. All primary care pro-
viders were salaried and there were no specific economic
incentives (i.e. no bonuses of any kind) for individual
providers during the study period.
Information on all ambulatory services, including visits,
diagnoses, procedures and tests, was maintained elec-
tronically for all members as part of an Automated Med-
ical Record System (AMRS.)[14] These data have been
used in previous studies. [15–17] The Staff Model HMO
contracted with area hospitals for inpatient services. For
hospitalization and other outside utilization, the HMO
maintains claims data using ICD-9 codes; this data struc-
ture contains up to six diagnoses and up to 3 surgical
procedures per claim.
Group model HMO
The Group Model division of HPHC included 16 medical
groups in 1993 that contracted with the HMO on a non-
exclusive basis, i.e. they were exclusive with regard to
other managed care plans, but not with respect to indem-
nity insurance. Most were primary care groups but a
small number were multispecialty groups. Payment of
groups was based on various forms of capitation; the
most common arrangement was for groups to be capitat-
ed for both primary and specialty outpatient care, and for
hospitalization risk to be shared in a wider pool. Capita-
tion rates and details such as loss-limit provisions varied
from group to group. Almost all groups comprised be-
tween 5 and 10 physicians.
Data from the Group Model were obtained from claims
that were submitted to the HMO to document care for
calculations pertinent to loss-limit provisions, even
though payments were not based on the claims them-
selves. Data files contained information on services pro-
vided in the offices of the primary care clinicians, on
outpatient services not provided by the primary care pro-
vider, (i.e. referrals), and on hospitalizations. Diagnoses
and procedures were coded using ICD-9 and CPT-4
codes.BMC Health Services Research 2001, 1:11 http://www.biomedcentral.com/1472-6963/1/11
Demographic and insurance coverage information on
members in the study were obtained from HMO enroll-
ment files.
Fee-for-service
Medicare beneficiaries were included in this study if they
were: age 65 and older as of January 1, 1994; had both
Part A and B coverage for at least 12 consecutive months
during 1994 and 1995; were not enrolled in an HMO dur-
ing these 12 consecutive months; and resided within the
HMO catchment area (see below).
We matched Medicare members enrolled in the HMO
with those in fee-for-service by area of residence. First,
we constructed a list of the zip codes in which eligible
HMO members resided during the study period. We con-
structed a list of Medicare fee-for-service beneficiaries
residing in the comparison area consisting of all contigu-
ous zip codes in which at least one HMO Medicare bene-
ficiary resided. The resulting sample included 339,627
people.
Data for the fee-for-service sample were obtained from
an enrollment file for demographic information, the
MedPAR (Medicare Provider Analysis and Review) file
for hospitalization claim data, Part B physician/supplier
claims file, and Hospital Outpatient Department claims
file.
Performance indicators
We developed performance measures that met several or
all of the following criteria: the disease or condition was
relatively common and potentially severe; a clinical serv-
ice that could affect the health outcome of the patient
was identifiable; the performance of the indicated serv-
ice depended in part on the role of a physician or health
system and not only on the patient; service performance
was potentially subject to financial incentives; it was pos-
sible from other research to assume that the indicated
service would on average improve outcome; and data to
construct the indicator were currently or potentially
available.
Our indicators assessed access to health care in three do-
mains (Table 1): 1) preventive care, including services
that provide future, not current, benefit; 2) diagnosis-
specific care, examining treatment for acute conditions
or episodes of disease; and 3) chronic disease care, in-
cluding secondary prevention. The selection of preven-
tive care indicators was guided by the generic
applicability of these maneuvers in this age group, mak-
ing it unnecessary to define a special population for
whom the procedure would be indicated. The indicators
of timely follow-up after hospitalization (diagnosis-spe-
cific care) were selected based on the seriousness of the
medical conditions; [18] the time interval between hos-
pital discharge and outpatient visit were determined by a
panel of physicians.
A panel of national experts in access to quality health
care, convened by the Health Care Financing Adminis-
tration in March of 1996, suggested additions to our orig-
inal indicator set. We then selected those that best met
the structured evaluation criteria, including at least two
indicators in each of the domains. Table 1 shows the in-
dicators organized by domains. More complete defini-
tions of inclusion criteria and coding, including specific
AMRS, ICD-9 and CPT codes used, have been published
elsewhere [19] and are summarized in 1Additional file
Indicator Definitions.
Statistical analyses
We compared the three samples by age category using
the chi-square test. For annual indicators, we averaged
utilization rates for 1994 and 1995; the denominators
were individuals eligible for each calendar year. We cal-
culated rates in three age strata: age 65–74, 75–84, and
85 years and older. We also calculated age-adjusted rates
standardized to the fee-for-service sample. Analyses
were performed using SAS.[20] We conducted two-way
comparisons of age-adjusted rates across the three sam-
ples (Staff Model, Group Model, and fee-for-service) us-
ing the chi-square test.
Results
Demographic characteristics of the study subjects are
shown in Table 2. The FFS population in the region un-
der study was older than the nationwide Medicare popu-
lation, and a slightly larger proportion was female (62%
versus 60%, p < 0.001). Those enrolled in the HMO were
younger than both the geographically matched, fee-for-
service sample and Medicare enrollees in the US as a
whole (p < 0.001), and they were less likely to be female
(p 0.001).
Age-adjusted rates of breast cancer screening with mam-
mography were substantially higher in the two HMO set-
tings than under fee-for-service insurance. (Table 3).
Mammography screening rates in the Staff Model were
nearly double those in the FFS sample. The proportion of
Medicare enrollees who saw a clinician within a one-year
period (Annual visit rate, Table 3) was greater than 85%
in all three groups; however, this rate was significantly
higher in the Staff Model HMO (94%) than the fee-for-
service sample (88%)(p < 0.001).
Proportion with follow up by either a primary care phy-
sician or cardiologist within 60 days of hospital dis-
charge after myocardial infarction (Table 4) was similar
in the two managed care divisions and, in both cases,BMC Health Services Research 2001, 1:11 http://www.biomedcentral.com/1472-6963/1/11
higher than under fee-for-service insurance (91% and
93% in the Staff and Group Model respectively, com-
pared to 73% in FFS; p < 0.001). Follow up within 14
days after hospitalization for depression was highest in
the Group Model HMO, although small sample size lim-
ited our ability to find statistically significant differences
(p > 0.3).
Care of chronic diseases is summarized in Table 5.
Screening rates for diabetic retinopathy were higher in
both divisions of the managed care organization than in
the fee-for-service sample. The proportion of diabetics
with 2 or more visits was 50% higher in managed care
than in fee-for-service (95% and 91% in the Staff and
Group Model, respectively, versus 61% in FFS, p <
0.001).
Discussion
We developed a set of indicators of access to effective
care for elderly people insured by Medicare designed to
fit varying clinical settings, insurance structures, and
data systems. In general, performance in both the Staff
and Group Model divisions of the managed care plan
studied was equivalent to or better than that in the fee-
Table 1: Medicare Performance Indicators
Domain/Indicator Population Measurement
Preventive and Primary Care
Breast cancer screening rate Women 65 yrs + % with mammogram in two years
Annual visit rate All beneficiaries % with at least one visit to primary care physician or specialist in a 
twelve month period
Diagnosis-Specific Care
Post-hospitalization follow-up for:
Myocardial infarction of those hospitalized for myocardial 
infarction
% with at least one cardiology or primary care visit within 60 days 
of discharge
Depression of those hospitalized for depression % with at least one mental health or primary care visit within 14 
days of discharge
Chronic Disease Care
Diabetes: Retinal screening of those with diabetes diagnosis % with retinal examination in a following 12 month period
Diabetes: Visit rate of those with diabetes diagnosis % with at least 2 visits to primary care or endocrinology in a fol-
lowing 12 month period
Table 2: Age and Gender (%) of Elderly Medicare Beneficiaries
Fee-for-Service Sample Managed Care Sample
United States Staff Model Group Model
N = 32,800,745 N= 344,733 N= 8,920 N= 4,258
Female * 60 62 56 55
Age (years)†
65–69‡ 30 23 42 44
70–74 § 26 29 28 24
75–79 ** 20 23 18 16
80–84 †† 13 15 8 9
85+ ‡‡ 11 10 4 7
*p < 0.001 for all two-way comparisons, except Staff/Group, p= 0.28  † Chi – square for all ages = 11,128; p = 0.001 ‡ p < 0.001 for all two-way 
comparisons, except Staff/Group, p = 0.03  §p < 0.001 for all two-way comparisons, except FFS/Staff, p = 0.04  **p < 0.001 for all two-way compar-
isons, except Staff/Group, p = 0.005  †† p < 0.001 for all two-way comparisons, except Staff/Group, = 0.05  ‡‡ p < 0.001 for all two-way compari-
sonsBMC Health Services Research 2001, 1:11 http://www.biomedcentral.com/1472-6963/1/11
Table 3: Preventive and Primary Health Care
Fee-for-Service Sample Managed Care Sample
Staff Model Group Model
N= 211,026 N= 1,638 N = 910
BREAST CANCER SCREENING RATE
All eligibles (age-adjusted)* 40.8 77.0 64.8
Age 65–74 53.7 86.6 78.1
Age 75–84 35.9 76.6 61.2
Age 85 and older 12.2 46.7 31.1
*p = 0.001 for all two-way comparisons
Fee-for-Service Staff Model Group Model
N = 325,984 N = 500 N = 500
ANNUAL VISIT RATE
All eligibles (age-adjusted)* 88.4 93.9 90.9
Age 65–74 86.0 95.0 89.7
Age 75–84 90.6 91.6 92.7
Age 85 and older 91.4 97.6 90.0
*p = 0.001 for Fee-for-Service/Staff Model Comparison
Table 4: Percent with Follow-up After Hospitalization
Fee-for-Service Sample             Managed Care Sample
Staff Model Group Model
N = 5,942 N = 162 N = 68
MYOCARDIAL INFARCTION*
All eligibles (age adjusted)† 73.3 90.7 93.2
Age 65–74 77.6 94.3 94.9
Age 75–84 73.4 92.3 89.4
Age 85 and older 60.2 75.0 100
Fee for Service Staff Model Group Model
N = 1,858 N = 29 N = 17
DEPRESSION ‡
All eligibles (age-adjusted)§ 65.8 64.5 80.3
Age 65–74 68.0 79.1 87.5
Age 75–84 64.8 53.4 75.0
Age 85 and older 63.0 --** --**
*Follow up within 60 days of hospital discharge  † p < 0.001 for Fee-for-Service/Staff Model and Fee-for-Service/Group Model comparisons  ‡ Follow 
up within 14 days of hospital discharge §p for each comparison > 0.3  **No hospitalizations occurred for this age groupBMC Health Services Research 2001, 1:11 http://www.biomedcentral.com/1472-6963/1/11
for-service sector. Other investigators have devised ad-
ministrative claims-based indicators, [21,22] and chart
review-based indicators for hospitals, [23] and ambula-
tory care sites, [24] in efforts to compare hospital per-
formance or health plan performance. In contrast, we
explored the feasibility of using data elements available
in an automated outpatient medical record, which are in-
creasingly prevalent, in addition to those available in
claims databases. The indicators we selected overlap
with those chosen to be included in the Health Plan Em-
ployer Data and Information Set (HEDIS) for the Medi-
care population, released in 1997, which also evaluates
breast cancer screening and retinal screening for diabet-
ics. [25]
Previous studies comparing performance indicators
across insurance types have found inconsistent results.
HMO performance on preventive services is consistently
higher than in FFS settings. [26–28] On the other hand,
some studies' findings have raised a concern that vulner-
able populations such as the chronically ill [29] and the
elderly [30] fare less well in HMOs than in FFS care. In
the Medicare population, data to support concern about
worse outcomes of care in HMOs has come from a na-
tional telephone survey about persistence of symptoms.
[29]
In numerous other investigations, however, care for the
Medicare population provided by HMOs has been shown
to be comparable to that in FFS. No differences between
HMO and FFS samples were found in studies of care for
colon cancer, [31,3,2] breast cancer,[33,34] prostate can-
cer,[35] cardiovascular disease,[36] rheumatoid arthri-
tis,[37] congestive heart failure, [38] hypertension, [39]
acute myocardial infarction,[40] acute appendicitis, [41]
and stroke. [42] One study found that functional status
did not decline faster among Medicare recipients en-
rolled in HMOs versus those in FFS. [43] Our findings
are consonant with these previous studies: for example,
a higher rate of mammography screening as seen in our
managed care population could explain the trend to ear-
lier stage breast cancers seen in California among HMO
enrollees compared to FFS.[31], [32]  While most of pre-
vious work focussed on specific disease entities, we stud-
ied the general Medicare population and measured
indicators applicable to all enrollees, as well as indicators
focussed on specific disease-populations.
There are few studies of the effect of managed care struc-
ture, (e.g. Group vs. Staff vs. IPA models) on indicators
of quality care. [44,45] These models differ both in the
extent to which financial risk is attached to individual
providers, and also the degree to which providers are ef-
fectively formed into an organized system of care. For ex-
ample some of the differences seen in our study between
the Group and Staff Model were probably due to organi-
zational processes and systems in place in the Staff Mod-
el, such as physician reminder systems for preventive
services leading to higher rates of breast cancer screen-
ing.
This study has several strengths. We included a large
number of Medicare enrollees covered by the health plan
studied, and the universe of fee-for-service Medicare en-
Table 5: Chronic Disease Care
Fee-for-Service Sample Managed Care Sample
Staff Model Group Model
N = 34,260 N = 1,092 N = 495
RETINAL EXAM RATE FOR DIABETIC PATIENTS
All eligibles (age-adjusted)* 54.8 67.5 63.9
Age 65–74 53.1 64.8 61.6
Age 75–84 57.3 68.9 67.1
Age 85 and older 52.2 76.0 62.1
*p < 0.001 for Fee-for-Service/Staff Model and Fee-for-Service/Group Model Comparisons
VISIT RATE FOR DIABETICS
All eligibles (age-adjusted)* 61.2 94.6 90.7
Age 65–74 59.4 95.4 91.5
Age 75–84 61.9 92.5 90.7
Age 85 and older 67.0 100.0 88.0
*p < 0.001 for all two-way comparisons, except Staff/Group p = 0.004BMC Health Services Research 2001, 1:11 http://www.biomedcentral.com/1472-6963/1/11
rollees in the same geographic region. Matching by re-
gion reduces the variation that may have affected some
previous comparisons of FFS and HMO populations, in
which national samples were used. [46] This method
also automatically accounts for any "spillover" effect of
managed care practices onto fee-for service practice,
wherein cost-saving techniques are applied widely by
providers, even to those with fee-for-service insurance,
in a market with high penetration of managed care insur-
ance. [47] In contrast to studies that focus on inpatient
data (in part because of their ready availability,)[48] our
focus on outpatient care is highly relevant to compari-
sons of managed care with fee-for-service care[49] in
terms of ambulatory practices that may prevent hospital-
izations. Our work on the time period 1994–95 follows
the transformations in managed care in 1991–1993, and
thus can been seen as an update to previous studies of
the topic.[13]
Our study also has limitations. People enrolling in man-
aged care organizations may be systematically different
from those choosing fee-for-service arrangements. [50]
For example, patients who are sicker or more disabled
may not enroll,[28] or may differentially choose to leave
managed care. [51] Those who do enroll could be more
aggressive in seeking care. We know that a smaller pro-
portion of HMO enrollees were over the age of 85 years,
compared to the matched fee-for-service sample. Differ-
ential enrollment could influence our results if patients
with higher degrees of co-morbid conditions preferen-
tially enrolled in the fee-for service system and did not
participate in cancer screening or secondary diabetic
prevention because of their other illnesses. [52] In addi-
tion, the annual visit rate could potentially be overesti-
mated in the HMO population if an influx of new patients
and a "new enrollee" effect were to cause more patients
to come in for visits than otherwise would. Another po-
tentially important limitation is that different data sys-
tems created for different purposes, such as claims and
clinical databases, may not provide comparable results,
even for strictly defined indicators.[53,54]
The use of performance indicators to compare care pro-
vided in different settings usually requires expensive
data gathering. Indicators based on automated data sys-
tems offer partial relief to this problem. Our findings re-
lated to staff model and group model HMO types should
be replicated in other settings, and extended to other
types of managed care. While the staff model HMO share
of the market is shrinking, group and network model
health maintenance organizations are experiencing in-
creased enrollment. Our finding of concordance on many
indicators between the Group and Staff Model divisions
suggests that a less tightly organized provider system
may perform as well as a staff model HMO. Neither of the
HMO divisions studied resembles an independent prac-
tice association (IPA) model, so our findings may not ap-
ply to that form of provider organization. In addition we
studied only one managed care organization, one that is
well established, and exists in a region of the country
with high level access to specialty services. The general-
izability of our findings to other managed care popula-
tions is unknown. Furthermore, the single HMO studied
is a not-for profit organization, and our findings might
not be applicable to for-profit entities. [55]
Conclusions
In conclusion, we believe that the indicators we have
tested are feasible to implement in other managed care
systems, and could be translated into other electronic
medical record systems. Indicators such as these might
be useful for consumers in comparing health plans to one
another, such as those participating in Medi-
care+Choice. We found no evidence of any decrement in
access to health care for the elderly Medicare population
enrolled in one managed care plan in this geographic re-
gion. The low- or no cost "supplemental" insurance pro-
vided by many HMOs may in fact lower financial barriers
to care for low-income seniors. Our study describes only
two models of managed care, and this is a crude classifi-
cation by current standards. Yet to be studied are the ef-
fects of financial incentives on increasingly smaller units
of leverage, e.g. small IPA model groups, and the effec-
tiveness of managed care plans that use sophisticated in-
formation systems to track and improve care, as
compared to those that use principally financial incen-
tives. [56,57] The latter is crucial to understanding how
best to create a partnership between providers and
health plans that facilitates the provision of excellent
care.
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